Company intelligence / Profile preview
ApicHope Pharmaceutical Group
Guangzhou, Guangdong, Chinaapichope.com ↗
- Ownership
- Private
- Employees
- ~1676
- Development stage
- Other
01
Overview
ApicHope Pharmaceutical Group is a leading Chinese pharmaceutical company with a broad portfolio of approved drugs focused on pediatric medicines, antivirals, antibiotics, and chronic disease therapies. The company has over 48 clinical trials registered and several products approved in China since 2002. Its pipeline includes both innovative small molecules and vaccines[1][2][3].
- Therapeutic areas
- PulmonologyCardiovascularInfectious Diseases
- Modalities
- Small moleculeProphylactic vaccineVirus-like particle vaccineChemical drugDegradable molecular glue
- Industry
- Biotech
02
Drug pipeline
18 assets17 more assets in the full pipeline.
03
Partnerships
Joint venture with Arthrosi Therapeutics for innovative drug development in China
Beyond the preview
Go deeper on ApicHope Pharmaceutical Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ApicHope Pharmaceutical Group.